Chapter 1 - Epidemiology and Etiology of Ovarian Cancer
Chapter 2 - Inflammation and Ovarian Cancer
Chapter 3 - Photonic Sensor System for Screening Serum Biomarker Proteins in Ovarian Cancer
Chapter 4 - The Role of MUC16 Mucin (CA125) in the Pathogenesis of Ovarian Cancer
Chapter 5 - Apoptosis Pathways in Ovarian Cancer
Chapter 6 - Oncogenic Pathway Signatures and Survival Outcome
Chapter 7 - Dysregulated TGF – Signaling in Ovarian Cancer
Chapter 8 - New Tumor Biomarkers in Ovarian Cancer and Its Prognostic and Clinical Relevance
Chapter 9 - Sensitive Detection of Epithelial Ovarian Cancer Biomarkers Using Tag-Laser Induced Breakdown Spectroscopy
Chapter 10 - Homeobox Genes and Their Functional Significance in Ovarian Tumorigenesis
Chapter 11 - Transcriptomic Analysis of Human Ovarian Cancer Cells: Changes Mediated by Luteinizing Hormone Receptor Activation
Chapter 12 - Potential Tumor Biomarkers for Ovarian Cancer
Chapter 13 - Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets
Chapter 14 - P53 Network in Ovarian Cancer
Chapter 15 - Gene Amplification in Ovarian Carcinomas: Lessons from Selected Amplified Gene Families
Chapter 16 - Nitric Oxide/Protein Kinase G-I? Promotes c-Src Activation, Proliferation and Chemoresistance in Ovarian Cancer
Chapter 17 - VEGF Targeting Agents in Ovarian Cancer
Chapter 18 - Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?
Chapter 19 - Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
